Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:33158149  

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.

Andreia Brandão | Paula Paulo | Sofia Maia | Manuela Pinheiro | Ana Peixoto | Marta Cardoso | Maria P Silva | Catarina Santos | Rosalind A Eeles | Zsofia Kote-Jarai | Kenneth Muir | Ukgpcs Collaborators | Johanna Schleutker | Ying Wang | Nora Pashayan | Jyotsna Batra | Apcb BioResource | Henrik Grönberg | David E Neal | Børge G Nordestgaard | Catherine M Tangen | Melissa C Southey | Alicja Wolk | Demetrius Albanes | Christopher A Haiman | Ruth C Travis | Janet L Stanford | Lorelei A Mucci | Catharine M L West | Sune F Nielsen | Adam S Kibel | Olivier Cussenot | Sonja I Berndt | Stella Koutros | Karina Dalsgaard Sørensen | Cezary Cybulski | Eli Marie Grindedal | Jong Y Park | Sue A Ingles | Christiane Maier | Robert J Hamilton | Barry S Rosenstein | Ana Vega | The Impact Study Steering Committee And Collaborators | Manolis Kogevinas | Fredrik Wiklund | Kathryn L Penney | Hermann Brenner | Esther M John | Radka Kaneva | Christopher J Logothetis | Susan L Neuhausen | Kim De Ruyck | Azad Razack | Lisa F Newcomb | Canary Pass Investigators | Davor Lessel | Nawaid Usmani | Frank Claessens | Manuela Gago-Dominguez | Paul A Townsend | Monique J Roobol | The Profile Study Steering Committee | The Practical Consortium | Manuel R Teixeira
Cancers | 2020

The identification of recurrent founder variants in cancer predisposing genes may have important implications for implementing cost-effective targeted genetic screening strategies. In this study, we evaluated the prevalence and relative risk of the CHEK2 recurrent variant c.349A>G in a series of 462 Portuguese patients with early-onset and/or familial/hereditary prostate cancer (PrCa), as well as in the large multicentre PRACTICAL case-control study comprising 55,162 prostate cancer cases and 36,147 controls. Additionally, we investigated the potential shared ancestry of the carriers by performing identity-by-descent, haplotype and age estimation analyses using high-density SNP data from 70 variant carriers belonging to 11 different populations included in the PRACTICAL consortium. The CHEK2 missense variant c.349A>G was found significantly associated with an increased risk for PrCa (OR 1.9; 95% CI: 1.1-3.2). A shared haplotype flanking the variant in all carriers was identified, strongly suggesting a common founder of European origin. Additionally, using two independent statistical algorithms, implemented by DMLE+2.3 and ESTIAGE, we were able to estimate the age of the variant between 2300 and 3125 years. By extending the haplotype analysis to 14 additional carrier families, a shared core haplotype was revealed among all carriers matching the conserved region previously identified in the high-density SNP analysis. These findings are consistent with CHEK2 c.349A>G being a founder variant associated with increased PrCa risk, suggesting its potential usefulness for cost-effective targeted genetic screening in PrCa families.

Pubmed ID: 33158149

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: UG1 CA189974
  • Agency: Cancer Research UK, United Kingdom
    Id: A8197/A16565
  • Agency: NIH HHS, United States
    Id: U19 CA 148537, X01HG007492
  • Agency: NIH HHS, United States
    Id: NCI U01 CA188392
  • Agency: NCI NIH HHS, United States
    Id: P30 CA016672
  • Agency: NCI NIH HHS, United States
    Id: U10 CA037429
  • Agency: Cancer Research UK, United Kingdom
    Id: C5047/A7357, C1287/A10118, C1287/A16563, C5047/A3354, C5047/A10692, C16913/A6135

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


PLINK (tool)

RRID:SCR_001757

Open source whole genome association analysis toolset, designed to perform range of basic, large scale analyses in computationally efficient manner. Used for analysis of genotype/phenotype data. Through integration with gPLINK and Haploview, there is some support for subsequent visualization, annotation and storage of results. PLINK 1.9 is improved and second generation of the software.

View all literature mentions

BEAGLE (tool)

RRID:SCR_001789

Software package for analysis of large-scale genetic data sets with hundreds of thousands of markers genotyped on thousands of samples. BEAGLE can * phase genotype data (i.e. infer haplotypes) for unrelated individuals, parent-offspring pairs, and parent-offspring trios. * infer sporadic missing genotype data. * impute ungenotyped markers that have been genotyped in a reference panel. * perform single marker and haplotypic association analysis. * detect genetic regions that are homozygous-by-descent in an individual or identical-by-descent in pairs of individuals. Beagle can also be used in conjunction with PRESTO, a program for fast and flexible permutation testing. PRESTO can compute empirical distributions of order statistics, analyze stratified data, and determine significance levels for one-stage and two-stage genetic association studies. BEAGLE is written in Java and runs on any computing platform with a Java version 1.6 interpreter (e.g. Windows, Unix, Linux, Solaris, Mac).

View all literature mentions

Primer-BLAST (tool)

RRID:SCR_003095

A tool to design target-specific primers for polymerase chain reaction (PCR). It uses Primer3 to design PCR primers and then uses BLAST and global alignment algorithm to screen primers against user-selected database in order to avoid primer pairs (all combinations including forward-reverse primer pair, forward-forward as well as reverse-reverse pairs) that can cause non-specific amplifications.

View all literature mentions

ClinVar (tool)

RRID:SCR_006169

Archive of aggregated information about sequence variation and its relationship to human health. Provides reports of relationships among human variations and phenotypes along with supporting evidence. Submissions from clinical testing labs, research labs, locus-specific databases, expert panels and professional societies are welcome. Collects reports of variants found in patient samples, assertions made regarding their clinical significance, information about submitter, and other supporting data. Alleles described in submissions are mapped to reference sequences, and reported according to HGVS standard.

View all literature mentions

HARDY (tool)

RRID:SCR_009107

Markov chain Monte Carlo program for association in two-dimensional contingency tables, and for testing Hardy-Weinberg equilibrium. (entry from Genetic Analysis Software)

View all literature mentions

POPART (tool)

RRID:SCR_021924

Software package that provides implementation of haplotype network methods, phylogeographic visualisation tools and standard statistical tests, together with publication ready figure production.Population genetics software. Used to understand evolutionary relationships among populations.

View all literature mentions